Pegylated asparaginase as cause of fatal hyperammonemia in patients with latent urea cycle disorder
- 18 May 2018
- journal article
- letter
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 65 (9) , e27239
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Inborn Metabolic Diseases2016
- Whole-Exome Sequencing and Whole-Genome Sequencing in Critically Ill Neonates Suspected to Have Single-Gene DisordersCold Spring Harbor Perspectives in Medicine, 2015
- Clinical Utility of Ammonia Concentration as a Diagnostic Test in Monitoring of the Treatment with L-Asparaginase in Children with Acute Lymphoblastic LeukemiaBioMed Research International, 2014
- High Incidence of Symptomatic Hyperammonemia in Children with Acute Lymphoblastic Leukemia Receiving Pegylated Asparaginase2012
- Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panelLeukemia & Lymphoma, 2011
- Mutant alleles associated with late-onset ornithine transcarbamylase deficiency in male patients have recurrently arisen and have been retained in some populationsJournal of Human Genetics, 2009
- Distinct fluctuations of ammonia levels during asparaginase therapy for childhood acute leukemiaPediatric Blood & Cancer, 2006
- ‘Late Onset’ Ornithine Transcarbamylase Deficiency: Function of Three Purified Recombinant Mutant EnzymesHuman Molecular Genetics, 1997
- Seven new mutations in the human ornithine transcarbamylase geneHuman Mutation, 1994